In a pathological setting, cell of origin (COO) subtype as germinal center B-cell (GCB) and non-GCB (6), as well as BCL2 (≥50%) and MYC (≥40%) double expressors (7), are recognized as important prognostic factors in DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.